{"id":"https://openalex.org/W7225182158","doi":"https://doi.org/10.3389/fphar.2026.1955923","title":"A literature-informed pharmacokinetic framework for polymyxin B dosing during continuous renal replacement therapy: integrating renal function and extracorporeal clearance","display_name":"A literature-informed pharmacokinetic framework for polymyxin B dosing during continuous renal replacement therapy: integrating renal function and extracorporeal clearance","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225182158","doi":"https://doi.org/10.3389/fphar.2026.1955923"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1955923","doi":"https://doi.org/10.3389/fphar.2026.1955923","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1955923","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1955923/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1955923/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160426980","display_name":"Aoao Pei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173759888","display_name":"Hunan Normal University","ror":"https://ror.org/053w1zy07","country_code":"CN","type":"education","lineage":["https://openalex.org/I173759888"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Aoao Pei","raw_affiliation_strings":["Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, College of Life Sciences, Hunan Normal University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, College of Life Sciences, Hunan Normal University","institution_ids":["https://openalex.org/I173759888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067516105","display_name":"Tong Wu","orcid":"https://orcid.org/0000-0003-4680-0129","observed_orcids":["https://orcid.org/0000-0003-4680-0129"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210156904","display_name":"Third Xiangya Hospital","ror":"https://ror.org/05akvb491","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156904"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tingting Wu","raw_affiliation_strings":["Department of Pharmacy, The Third Xiangya Hospital, Central South University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Third Xiangya Hospital, Central South University","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210156904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135271106","display_name":"Jingjing Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210156904","display_name":"Third Xiangya Hospital","ror":"https://ror.org/05akvb491","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156904"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jingjing Liu","raw_affiliation_strings":["Department of Intensive Medicine, The Third Xiangya Hospital, Central South University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Intensive Medicine, The Third Xiangya Hospital, Central South University","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210156904","https://openalex.org/I4210159865"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102855849","display_name":"Xing Feng","orcid":"https://orcid.org/0000-0002-6908-5917","observed_orcids":["https://orcid.org/0000-0002-6908-5917"]},"institutions":[{"id":"https://openalex.org/I173759888","display_name":"Hunan Normal University","ror":"https://ror.org/053w1zy07","country_code":"CN","type":"education","lineage":["https://openalex.org/I173759888"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xing Feng","raw_affiliation_strings":["Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, College of Life Sciences, Hunan Normal University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, College of Life Sciences, Hunan Normal University","institution_ids":["https://openalex.org/I173759888"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102855849","https://openalex.org/A5135271106"],"corresponding_institution_ids":["https://openalex.org/I139660479","https://openalex.org/I173759888","https://openalex.org/I4210156904","https://openalex.org/I4210159865"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84992124,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polymyxin-b","display_name":"polymyxin B","score":0.9940000176429749},{"id":"https://openalex.org/keywords/continuous-renal-replacement-therapy","display_name":"continuous renal replacement therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-dosage","display_name":"drug dosing","score":0.6119999885559082},{"id":"https://openalex.org/keywords/residual-renal-function","display_name":"residual renal function","score":0.8389999866485596},{"id":"https://openalex.org/keywords/intrinsic-clearance","display_name":"intrinsic clearance","score":0.6579999923706055},{"id":"https://openalex.org/keywords/an69-membrane","display_name":"AN69 membrane","score":0.6710000038146973},{"id":"https://openalex.org/keywords/polysulfone-membranes","display_name":"polysulfone membranes","score":0.8579999804496765},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.5540000200271606},{"id":"https://openalex.org/keywords/shiny-app","display_name":"Shiny app","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2779541074","wikidata":"https://www.wikidata.org/wiki/Q185643","display_name":"Renal replacement therapy","level":2,"score":0.7533000111579895},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7088000178337097},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6969000101089478},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6721000075340271},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5382000207901001},{"id":"https://openalex.org/C2780026444","wikidata":"https://www.wikidata.org/wiki/Q1088175","display_name":"Polymyxin B","level":3,"score":0.5199999809265137},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46369999647140503},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4546000063419342},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.45419999957084656},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43810001015663147},{"id":"https://openalex.org/C2779915274","wikidata":"https://www.wikidata.org/wiki/Q1115882","display_name":"Extracorporeal","level":2,"score":0.42320001125335693},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.3601999878883362},{"id":"https://openalex.org/C138944611","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Clearance","level":2,"score":0.3379000127315521},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.3310000002384186},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.2696000039577484},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2621000111103058},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2612000107765198},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2524999976158142}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1955923","doi":"https://doi.org/10.3389/fphar.2026.1955923","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1955923","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1955923/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1955923","doi":"https://doi.org/10.3389/fphar.2026.1955923","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1955923","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1955923/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225182158.pdf","grobid_xml":"https://content.openalex.org/works/W7225182158.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W18840079","https://openalex.org/W1550111394","https://openalex.org/W1982090306","https://openalex.org/W2003049461","https://openalex.org/W2010352340","https://openalex.org/W2105929522","https://openalex.org/W2115729691","https://openalex.org/W2123264877","https://openalex.org/W2127840328","https://openalex.org/W2138095705","https://openalex.org/W2141559993","https://openalex.org/W2170001997","https://openalex.org/W2190702170","https://openalex.org/W2528978880","https://openalex.org/W2591157472","https://openalex.org/W2781961936","https://openalex.org/W2810570371","https://openalex.org/W2894202568","https://openalex.org/W2911566892","https://openalex.org/W2938996241","https://openalex.org/W2963565417","https://openalex.org/W2980375444","https://openalex.org/W3032253244","https://openalex.org/W3034104302","https://openalex.org/W3091638432","https://openalex.org/W3095908538","https://openalex.org/W3120867687","https://openalex.org/W3126381726","https://openalex.org/W3131147063","https://openalex.org/W3147894636","https://openalex.org/W3216835035","https://openalex.org/W4200313150","https://openalex.org/W4229069318","https://openalex.org/W4281259541","https://openalex.org/W4307939962","https://openalex.org/W4309094160","https://openalex.org/W4318184573","https://openalex.org/W4377141319","https://openalex.org/W4390397963","https://openalex.org/W4391248430","https://openalex.org/W4392812179","https://openalex.org/W4393066743","https://openalex.org/W4403069730","https://openalex.org/W4403287572","https://openalex.org/W4405242011","https://openalex.org/W4405398996","https://openalex.org/W4407152666","https://openalex.org/W4410089668","https://openalex.org/W4410875399","https://openalex.org/W4411737797","https://openalex.org/W4416918168","https://openalex.org/W7162993385"],"related_works":["https://openalex.org/W4281259541","https://openalex.org/W3091638432","https://openalex.org/W4220978183","https://openalex.org/W4377141319","https://openalex.org/W3006392666","https://openalex.org/W4283066718","https://openalex.org/W4392590114","https://openalex.org/W7127310765","https://openalex.org/W3196041263","https://openalex.org/W7221769438"],"abstract_inverted_index":{"Introduction":[0],"Existing":[1],"population":[2],"pharmacokinetic":[3,42],"(PopPK)":[4],"models":[5,39,57],"for":[6,80,92,113,120,156,261],"polymyxin":[7,81,185,292],"B":[8,82,186,293],"in":[9,188],"patients":[10,47,189],"receiving":[11,49,191,195],"CRRT":[12,50,63,192,196,215],"remain":[13],"limited,":[14],"and":[15,62,94,101,117,137,141,161,193,223,285,300,309,314],"all":[16],"of":[17,23,165,184,206,212,266],"them":[18],"have":[19,33],"neglected":[20],"the":[21,114,121,154,175,203,210,218,242,301],"impact":[22],"membrane":[24,116,220,244],"materials":[25],"on":[26,234],"drug":[27,207,316],"adsorption.":[28],"Recently,":[29],"a":[30,76,142,162,247],"few":[31],"studies":[32],"attempted":[34],"to":[35,74,90,110],"construct":[36,75],"integrated":[37,56],"PK":[38,78],"by":[40,88],"combining":[41],"(PK)":[43],"parameters":[44],"derived":[45],"from":[46],"not":[48,190],"with":[51,96,236,263],"CRRT\u2010specific":[52],"parameters.":[53],"However,":[54],"current":[55],"only":[58],"consider":[59],"non\u2010renal":[60],"clearance":[61,64,85],"(CLCRRT),":[65],"excluding":[66],"residual":[67],"renal":[68],"function":[69],"(RRF).":[70],"This":[71],"study":[72],"aimed":[73],"literature-informed":[77],"framework":[79,180,299],"incorporating":[83],"intrinsic":[84],"(CLintrinsic,":[86],"adjusted":[87],"CrCL":[89,235],"account":[91],"RRF)":[93],"CLCRRT,":[95],"CLCRRT":[97,106],"comprising":[98],"transmembrane":[99],"(CLTM)":[100],"adsorptive":[102],"(CLads)":[103],"components.":[104],"Methods":[105],"allocation":[107],"was":[108,128,202,276],"set":[109],"0%":[111],"CLads":[112,119],"PS":[115,219],"100%":[118],"AN69":[122,243],"membrane.":[123],"The":[124,179,297],"frameworks":[125],"predictive":[126],"performance":[127],"evaluated":[129],"using":[130],"two":[131],"literature":[132],"datasets":[133],"(n":[134,145],"=":[135,139,146,225],"53":[136],"n":[138],"30)":[140],"prospective":[143,311],"cohort":[144],"10).":[147],"Simulation":[148],"analyses":[149],"used":[150],"PTA":[151],"\u226590%":[152],"as":[153,174,306],"criterion":[155],"adequate":[157],"pharmacodynamic":[158],"target":[159],"attainment":[160],"simulated":[163],"probability":[164],"AUC":[166],"0\u201024":[167],"h":[168],">":[169],"100":[170],"mg\u00b7h/L":[171],"\u2264":[172],"14.5%":[173],"exposure\u2010exceedance":[176],"threshold.":[177],"Results":[178],"demonstrated":[181],"accurate":[182],"predictions":[183],"exposure":[187],"those":[194],"(prediction":[197],"error":[198],"<30%).":[199],"Filter":[200],"type":[201,284],"primary":[204],"determinant":[205],"exposure,":[208],"exceeding":[209],"effects":[211],"RRF":[213,286],"or":[214,238],"intensity.":[216],"For":[217,241],"(AV600S":[221],"filter)":[222],"MIC":[224,265],"0.5":[226,267],"mg/L":[227],"pathogens,":[228],"doses":[229],"should":[230,258,287],"be":[231,259,288],"stratified":[232],"based":[233],"standard":[237],"lower":[239],"doses.":[240],"(OXIRIS":[245],"filter),":[246],"high\u2010dose":[248],"regimen":[249],"(200":[250],"mg":[251,255],"LD":[252],"+":[253],"150":[254],"MD":[256],"q12h)":[257],"considered":[260,289],"infections":[262],"an":[264],"mg/L.":[268],"An":[269],"interactive":[270],"Shiny":[271,302],"application":[272,303],"(":[273],"https://xy3yx-cn.shinyapps.io/polymyxin-B-crrt-dosing/":[274],")":[275],"developed.":[277],"Discussion":[278],"These":[279],"findings":[280],"suggest":[281],"that":[282],"filter":[283],"when":[290],"individualizing":[291],"dosing":[294],"during":[295],"CRRT.":[296],"proposed":[298],"are":[304],"intended":[305],"research":[307],"tools":[308],"require":[310],"clinical":[312,320],"evaluation":[313],"therapeutic":[315],"monitoring":[317],"before":[318],"routine":[319],"use.":[321]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}